To the best of our knowledge, this is the first report that links Fgf6 expression in skeletal muscles to metabolic disorders, providing new insight into the role the environment-gene interaction network plays in the pathogenesis of obesity, and this insight might aid in the development of prevention and treatment strategies for metabolic diseases. Here, FGF6 is linked to metabolic disease.